EPISODE · Mar 1, 2024 · 19 MIN
S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC
from Treating Together · host Targeted Oncology
In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of patients with metastatic renal cell carcinoma and response to immunotherapy.
Embed this episode
Ready to play
S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC
0:00
19:03
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of Treating Together?
This episode is 19 minutes long.
When was this Treating Together episode published?
This episode was published on March 1, 2024.
Can I download this Treating Together episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!